Belgium vs Germany: Treatment success rate for patients treated for MDR-TB
Belgium
47.0%
in 2022
Germany
45.0%
in 2022
Belgium rank
146th
Germany rank
147th
Treatment success rate for patients treated for MDR-TB over time
- Belgium
- Germany
How they compare
Belgium currently reports 47.0% against 45.0% in Germany, a difference of 2.0%.
The two have swapped places 7 times across 19 shared years of data; in 2002 it was Germany ahead.
Belgium ranks 146th and Germany ranks 147th of 163 countries.
Across the 3 decades both report, Belgium averaged higher in 2 and Germany in 1.
Head to head by decade
| Decade | Belgium | Germany | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 51.0% | 60.3% | 9.3% | Germany |
| 2010s | 75.2% | 47.8% | 27.4% | Belgium |
| 2020s | 50.0% | 46.3% | 3.7% | Belgium |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Belgium or Germany?
- Belgium, at 47.0% against 45.0% in Germany as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Belgium and Germany?
- 2.0%, with Belgium ahead.
- How many years of comparable data are there for Belgium and Germany?
- 19 years are reported by both, from 2002 to 2022.
- How do Belgium and Germany rank globally for treatment success rate for patients treated for mdr-tb?
- Belgium ranks 146th and Germany ranks 147th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.